Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
by Professor Fabrizio Schifano and Dr Antonio Albanese
Last updated: February 2019
In the second half of the 1990s, a global trend of escalating stimulant misuse (such as cocaine, amphetamine, methamphetamine, methylenedioxymethamphetamine/ MDMA and MDMA-like drugs, cathinone derivatives, and benzylpiperazine/BZP) was observed across a number of EU countries.
When reorganising statutory and non-statutory services to cope with this increasingly widespread clinical issue, the epidemiological approach is of paramount importance, and a clear appreciation of the levels of stimulant misuse is necessary in order to allocate the appropriate levels of resources.
Stimulant misuse is typically associated with an imbalance of neurotransmitters, especially dopamine. Therefore, practising psychiatrists need to be aware of the psychopathological consequences related to substance misuse in order to refine their own diagnostic and clinical management skills.
Start the module
Stimulants: treatment approaches and organising services by Prof Fabrizio Schifano and Dr Antonio Albanese
Alcohol-related brain damage by Prof Kenneth Wilson, Dr Joy Bell and Dr Vanessa Craig
Buprenorphine in opioid dependence by Dr Lucinda M. Cockayne and Ms Elizabeth Hutchings
Helping the addicted doctor by Dr Elizabeth Hare and Dr Malcolm Bruce
Drug Misuse: Psychosocial Interventions - The NICE Guideline (book from RCPsych publications)
Related Advances articles
Download take-home notes to print and annotate